Your browser is no longer supported. Please, upgrade your browser.
Settings
TTNP Titan Pharmaceuticals, Inc. daily Stock Chart
TTNP [NASD]
Titan Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.53 Insider Own0.34% Shs Outstand93.78M Perf Week16.82%
Market Cap23.45M Forward P/E- EPS next Y-0.17 Insider Trans0.00% Shs Float82.95M Perf Month18.99%
Income-16.00M PEG- EPS next Q-0.08 Inst Own5.60% Short Float6.88% Perf Quarter56.54%
Sales3.60M P/S6.51 EPS this Y80.80% Inst Trans- Short Ratio0.31 Perf Half Y-19.35%
Book/sh-0.17 P/B- EPS next Y77.50% ROA-170.40% Target Price8.50 Perf Year-86.34%
Cash/sh0.01 P/C26.05 EPS next 5Y- ROE-962.90% 52W Range0.14 - 2.18 Perf YTD28.80%
Dividend- P/FCF- EPS past 5Y-17.10% ROI-74.50% 52W High-88.53% Beta0.84
Dividend %- Quick Ratio0.80 Sales past 5Y-8.80% Gross Margin71.70% 52W Low76.06% ATR0.05
Employees23 Current Ratio1.10 Sales Q/Q-47.10% Oper. Margin- RSI (14)50.37 Volatility13.15% 22.13%
OptionableYes Debt/Eq- EPS Q/Q71.70% Profit Margin- Rel Volume0.25 Prev Close0.26
ShortableYes LT Debt/Eq- EarningsMar 30 AMC Payout- Avg Volume18.25M Price0.25
Recom2.00 SMA20-2.79% SMA50-4.19% SMA200-47.31% Volume4,531,721 Change-2.15%
Jun-26-19Initiated Maxim Group Buy $4
Nov-10-17Downgrade ROTH Capital Buy → Neutral
Mar-26-20 08:00AM  Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020 PR Newswire
Mar-05-20 09:00AM  Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants PR Newswire +12.57%
Feb-18-20 08:55AM  Did Changing Sentiment Drive Titan Pharmaceuticals's (NASDAQ:TTNP) Share Price Down A Disastrous 99%? Simply Wall St.
Jan-13-20 08:00AM  Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule PR Newswire
Jan-07-20 09:15AM  Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering PR Newswire -19.83%
Dec-30-19 08:00AM  Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors PR Newswire +22.72%
Dec-17-19 10:30AM  Should You Worry About Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) CEO Pay? Simply Wall St.
Dec-04-19 01:22PM  Edited Transcript of TTNP earnings conference call or presentation 14-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-03-19 09:00AM  Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference PR Newswire +20.43%
Nov-25-19 05:15AM  TTNP: Waiting for Revenue Turn Zacks Small Cap Research
Nov-14-19 04:03PM  Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results PR Newswire +12.04%
Nov-07-19 04:30PM  Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow PR Newswire
Oct-22-19 08:00AM  Titan Pharmaceuticals To Present Two Posters On Probuphine® At The 10th American Conference On Pharmacometrics PR Newswire
Oct-18-19 10:23AM  These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals +5.11%
Oct-16-19 09:20AM  Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering PR Newswire -51.02%
Oct-01-19 08:00AM  Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facilities PR Newswire
Sep-18-19 08:00AM  Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant PR Newswire +20.91%
Aug-30-19 08:01PM  Edited Transcript of TTNP earnings conference call or presentation 14-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-23-19 11:30AM  TTNP: Long on Opportunity, Short on Capital Zacks Small Cap Research -6.17%
Aug-17-19 09:59AM  Some Titan Pharmaceuticals (NASDAQ:TTNP) Shareholders Have Copped A 99% Share Price Wipe Out Simply Wall St.
Aug-16-19 07:33AM  The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission Benzinga +7.51%
Aug-14-19 04:03PM  Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire
07:32AM  Q2 Earnings Preview For Titan Pharmaceuticals Benzinga
Aug-09-19 05:00PM  Titan Pharmaceuticals To Release Second Quarter 2019 Financial Results On August 14 - Conference Call To Follow PR Newswire
Aug-07-19 09:15AM  Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering PR Newswire -27.38%
Jul-09-19 09:00AM  Titan Pharmaceuticals Expands Patient Access To Probuphine® Via Specialty Product Distribution Agreement With CVS Caremark PR Newswire
Jul-03-19 10:54AM  What Does Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) Balance Sheet Tell Us About It? Simply Wall St.
Jun-26-19 09:10AM  Titan Pharmaceuticals And Molteni Receive European Regulatory Approval For Probuphine PR Newswire -5.56%
Jun-04-19 07:00AM  Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine® PR Newswire +11.61%
May-29-19 02:15PM  TTNP: A+ Partnerships: AllianceRx, AppianRx & Accredo Zacks Small Cap Research
May-23-19 08:10AM  Edited Transcript of TTNP earnings conference call or presentation 15-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-15-19 04:08PM  Titan Pharmaceuticals: 1Q Earnings Snapshot Associated Press
04:03PM  Titan Pharmaceuticals Reports First Quarter 2019 Financial Results PR Newswire
May-13-19 07:00AM  Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo® PR Newswire
May-08-19 08:00PM  Titan Pharmaceuticals To Release First Quarter 2019 Financial Results On May 15 - Conference Call To Follow PR Newswire
May-06-19 03:12PM  Edited Transcript of TTNP earnings conference call or presentation 2-Apr-19 12:30pm GMT Thomson Reuters StreetEvents
Apr-29-19 07:00AM  Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine® PR Newswire
Apr-12-19 05:00PM  Knight Therapeutics: Use of PROBUPHINE for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast GlobeNewswire
Apr-11-19 09:45AM  TTNP: EMA Approval of Probuphine Expected 2Q:19 Zacks Small Cap Research
Apr-02-19 01:06AM  /C O R R E C T I O N -- Titan Pharmaceuticals, Inc./ PR Newswire
Apr-01-19 05:07PM  Titan Pharmaceuticals: 4Q Earnings Snapshot Associated Press
04:30PM  Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results PR Newswire
Mar-28-19 07:00AM  Titan Pharmaceuticals Partners With AppianRx To Provide Comprehensive Probuphine® Patient Support Services PR Newswire
Mar-26-19 07:00AM  Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019 PR Newswire
Feb-25-19 02:20PM  4 Healthcare Stocks Looking To Kick Off A Strong Week ACCESSWIRE +27.78%
07:00AM  Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine® PR Newswire
Feb-08-19 09:30AM  TTNP: Shipments Spike in 2H:18 Zacks Small Cap Research
Feb-01-19 02:31PM  4 Healthcare Stocks Looking To Start February Off Strong ACCESSWIRE +34.15%
12:01PM  How Many Insiders Bought Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Shares? Simply Wall St.
11:46AM  Why Titan Pharmaceuticals Stock Is Skyrocketing Today InvestorPlace
11:10AM  Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc. ACCESSWIRE
Jan-31-19 06:36PM  Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch PR Newswire
Jan-24-19 07:00AM  Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire
Dec-21-18 12:54PM  Edited Transcript of TTNP earnings conference call or presentation 14-Nov-18 9:15pm GMT Thomson Reuters StreetEvents -8.56%
Dec-10-18 10:35AM  Alternatives to Watch ACCESSWIRE
Nov-21-18 07:25AM  Factors of Influence in 2018, Key Indicators and Opportunity within Atlantic American, Titan Medical, Adial Pharmaceuticals, Aptinyx, Sotherly Hotels, and Titan Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Nov-20-18 11:15AM  TTNP: New CCO Implementing Targeted Strategy Zacks Small Cap Research
Nov-14-18 04:38PM  Titan Pharmaceuticals: 3Q Earnings Snapshot Associated Press +10.23%
04:01PM  Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results PR Newswire
Nov-08-18 07:00AM  Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results PR Newswire
Nov-07-18 09:30AM  Biotech Stocks and the Midterm Elections ACCESSWIRE
Nov-05-18 08:55AM  3 Stocks To Watch As Healthcare Market Evolves ACCESSWIRE +18.74%
07:00AM  Todays Research Reports on Stocks to Watch: Conatus Pharmaceuticals and Titan Pharmaceuticals ACCESSWIRE
Nov-02-18 10:30AM  Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday ACCESSWIRE +22.62%
Oct-30-18 09:45AM  3 Healthcare Stocks that Could Move on Industry Growth ACCESSWIRE -5.92%
Oct-29-18 08:00AM  Knight Therapeutics Announces the Canadian launch of PROBUPHINE for Opioid Use Disorder GlobeNewswire
Oct-23-18 02:40PM  These 3 Stocks Are Moving Higher This Month ACCESSWIRE +36.36%
Oct-22-18 08:00AM  Today's Research Reports on Trending Tickers: Titan Pharmaceuticals and Amarin Corporation ACCESSWIRE -6.98%
Oct-15-18 08:15AM  Titan Pharmaceuticals Moving Forward with its ProNeura Technology, Analysts Review ACCESSWIRE +11.88%
Oct-02-18 07:00AM  Titan Strengthens Executive Leadership Team With Appointment Of Chief Commercial Officer PR Newswire -5.62%
Sep-20-18 08:30PM  Titan Pharmaceuticals Prices $9,500,000 Public Offering PR Newswire -10.71%
09:32AM  Who Owns Titan Pharmaceuticals Inc (NASDAQ:TTNP)? Simply Wall St.
Sep-10-18 07:00AM  Titan Awarded NIDA Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse PR Newswire
Aug-20-18 05:55PM  Why this Peninsula company needs a cash fix 2 years after opioid addiction treatment approved American City Business Journals +9.70%
Aug-14-18 04:55PM  Titan Pharmaceuticals: 2Q Earnings Snapshot Associated Press
04:35PM  Titan Pharmaceuticals Reports Second Quarter 2018 Financial Results PR Newswire
Aug-03-18 07:00AM  Titan Announces Amendment To Agreement With Molteni PR Newswire
Jul-02-18 04:30PM  Titan Pharmaceuticals Provides Update On Parkinson's Disease Clinical Development Program PR Newswire
May-30-18 07:00AM  Titan Pharmaceuticals And Braeburn Announce Mutual Termination Of License Agreement For Probuphine® For Opioid Dependence PR Newswire +13.62%
May-24-18 02:03PM  Edited Transcript of TTNP earnings conference call or presentation 16-May-18 8:15pm GMT Thomson Reuters StreetEvents
May-16-18 08:10AM  Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings Benzinga
May-15-18 04:40PM  Titan Pharmaceuticals: 1Q Earnings Snapshot Associated Press
04:15PM  Titan Pharmaceuticals Reports First Quarter 2018 Financial Results PR Newswire
May-14-18 07:00AM  Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board PR Newswire +21.00%
May-08-18 05:05PM  Titan Pharmaceuticals To Report First Quarter 2018 Financial Results On May 15, 2018 PR Newswire -6.63%
Apr-12-18 09:30AM  TTNP: Molteni Investment Relieves the Pressure Zacks Small Cap Research
Apr-11-18 07:00AM  Wired News Conatus to Demonstrate Impact of Pan-caspase Inhibitor IDN-7314 in Reducing Inflammation and Liver Injury in Mouse Model of PSC at EASL Annual Meeting ACCESSWIRE
Apr-03-18 07:16AM  3 Stocks to Watch on Tuesday: Atlas Financial Holdings Inc (AFH), Eastside Distilling Inc (EAST) and Titan Pharmaceuticals, Inc. (TTNP) InvestorPlace
Apr-02-18 12:00PM  Titan Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
07:14AM  Titan Pharmaceuticals reports 4Q loss Associated Press
07:00AM  Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results PR Newswire
Mar-26-18 05:00PM  Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2017 Financial Results PR Newswire -7.67%
Mar-22-18 08:39AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +14.02%
Mar-21-18 05:05PM  Titan Executes Agreement For Acquisition By Molteni Of Probuphine® In Europe And Other Select Territories PR Newswire
Mar-19-18 02:30PM  Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors GlobeNewswire
Feb-02-18 05:15PM  Titan Announces Amendment To Horizon Loan Agreement PR Newswire
Feb-01-18 11:40AM  Titan (TTNP) Negotiating with Braeburn for Probuphine Zacks Small Cap Research
Jan-22-18 07:00AM  Titan In Discussions With Braeburn Regarding U.S. Probuphine® Commercialization PR Newswire
Jan-05-18 07:10PM  What Should Investors Know About Titan Pharmaceuticals Incs (NASDAQ:TTNP) Growth? Simply Wall St.
Dec-26-17 12:15PM  ETFs with exposure to Titan Pharmaceuticals, Inc. : December 26, 2017 Capital Cube
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine, a six-month buprenorphine implant for the maintenance treatment of opioid addiction in patients. It also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.